Stock Research for PTX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

PTX Stock Chart & Research Data

The PTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PTX Due diligence Resources & Stock Charts

The PTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PTX Detailed Price Forecast - CNN Money CNN View PTX Detailed Summary - Google Finance
Yahoo View PTX Detailed Summary - Yahoo! Finance Zacks View PTX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View PTX Trends & Analysis - Trade-Ideas Barrons View PTX Major Holders - Barrons
NASDAQ View PTX Call Transcripts - NASDAQ Seeking View PTX Breaking News & Analysis - Seeking Alpha
Spotlight View PTX Annual Report - CompanySpotlight.com OTC Report View PTX OTC Short Report - OTCShortReport.com
TradeKing View PTX Fundamentals - TradeKing Charts View PTX SEC Filings - Bar Chart
WSJ View Historical Prices for PTX - The WSJ Morningstar View Performance/Total Return for PTX - Morningstar
MarketWatch View the Analyst Estimates for PTX - MarketWatch CNBC View the Earnings History for PTX - CNBC
StockMarketWatch View the PTX Earnings - StockMarketWatch MacroAxis View PTX Buy or Sell Recommendations - MacroAxis
Bullish View the PTX Bullish Patterns - American Bulls Short Pains View PTX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View PTX Stock Mentions - StockTwits PennyStocks View PTX Stock Mentions - PennyStockTweets
Twitter View PTX Stock Mentions - Twitter Invest Hub View PTX Investment Forum News - Investor Hub
Yahoo View PTX Stock Mentions - Yahoo! Message Board Seeking Alpha View PTX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for PTX - SECform4.com Insider Cow View Insider Transactions for PTX - Insider Cow
CNBC View PTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PTX - OTC Markets
Yahoo View Insider Transactions for PTX - Yahoo! Finance NASDAQ View Institutional Holdings for PTX - NASDAQ


Stock Charts

FinViz View PTX Stock Insight & Charts - FinViz.com StockCharts View PTX Investment Charts - StockCharts.com
BarChart View PTX Stock Overview & Charts - BarChart Trading View View PTX User Generated Charts - Trading View




Latest Financial News for PTX


Pernix Therapeutics Holdings, Inc.’s Subsidiaries File Notice of Appeal in Patent Litigation Concerning Zohydro® ER with BeadTek®
Posted on Wednesday September 12, 2018

Pernix Therapeutics Holdings, Inc. (PTX), announced today that, on September 7, 2018, its subsidiaries, Pernix Therapeutics, LLC, a specialty pharmaceutical company, and Pernix Ireland Pain Designated Activity Company, filed a notice of appeal to the United States Court of Appeals for the Federal Circuit in the Company’s litigation against Alvogen Malta Operations, Ltd. (Alvogen). The litigation relates to Alvogen’s submission of an Abbreviated New Drug Application (ANDA) to the U.S. Food & Drug Administration (FDA) seeking approval to market a generic version of Pernix’s Zohydro® ER with BeadTek® (hydrocodone bitartrate).  The United States District Court for the District of Delaware previously found the asserted claims of U.S. Patent Nos.


Edited Transcript of PTX earnings conference call or presentation 9-Aug-18 8:30pm GMT
Posted on Tuesday September 11, 2018

Q2 2018 Pernix Therapeutics Holdings Inc Earnings Call


Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek®
Posted on Monday August 27, 2018

Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today that in the Company’s litigation against Alvogen Malta Operations, Ltd. (Alvogen), the United States District Court for the District of Delaware found the asserted claims of U.S. Patent Nos. 9,265,760 and 9,339,499, which relate to methods of treating patients with mild and moderate hepatic impairment with hydrocodone bitartrate, to be infringed, but invalid.  The litigation relates to Alvogen’s submission of an Abbreviated New Drug Application (ANDA) to the U.S. Food & Drug Administration (FDA) seeking approval to market a generic version of Pernix’s Zohydro® ER with BeadTek® (hydrocodone bitartrate).


Pernix Therapeutics Reports Second Quarter 2018 Financial Results
Posted on Thursday August 09, 2018

MORRISTOWN, N.J., Aug. 09, 2018--. Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, announced today its financial results for the three and six months ended June 30, 2018.. Second ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.